By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Opinion: Buying this annuity guarantees that you’ll lose out on big money
Investing

Opinion: Buying this annuity guarantees that you’ll lose out on big money

News Room
Last updated: 2023/09/24 at 12:02 AM
By News Room
Share
7 Min Read
SHARE

I wrote recently that people who buy life insurance are effectively loaning money to insurance companies at around a 2.5% interest rate, which is a great deal for the companies and a lousy investment for the policyholders.

Here’s something even worse: qualified longevity annuity contracts (QLACs), which are sold by insurance companies and other financial-service firms.

QLACs are annuity contracts that pay a guaranteed monthly income for as long as a person lives. What distinguishes QLACs from standard annuities are: (1) the annuity payments are deferred in that they don’t begin until several years after the contract is purchased; and (2) they can be bought with tax-free withdrawals from retirement accounts (the annuity payments are taxable income).

A recent Wall Street Journal article noted that QLACs are typically bought by people nearing retirement who are worried that that they might outlive their retirement savings. One example is a 65-year-old (let’s call him Bob) who buys a $200,000 QLAC at age 65 and starts receiving monthly payments of $11,175 at age 85. That’s $134,100 a year, which sounds like a great return on a $200,000 investment.

Except this conclusion ignores two realities. The first is the miracle of compound interest. If Bob instead invests the $200,000 in stocks and averages a 10% annual return (roughly the historical average return on U.S. stocks), he will have more than $1.3 million when he is 85 years old. Second, 54% of all 65-year-old U.S. males don’t live to age 85. If Bob dies before 85, that’s $200,000 down the drain.

Bob can buy a QLAC with a death benefit that returns the $200,000 to his heirs, minus any annuity payments that have been made, but in that case his monthly annuity payments are reduced from $11,175 to $7,000. It is tempting to think that a QLAC with death benefits is an attractive option because the heirs get back the initial cost. But that myopic thinking again ignores the power of compound interest. There is an expensive opportunity cost of giving $200,000 to an insurance company and getting it back without interest 10-, 15-, or 20 years later.

What is the implied rate of return on a QLAC? It’s complicated, but a durable rule to remember is this: “If someone who is pretty smart offers to sell you an investment and it is really difficult to figure out the rate of return, the odds are that the rate of return is pretty bad.”

That is certainly the case here. To calculate the average rate of return for a QLAC, taking into account all the possible ages at death, we need life tables showing the probability of death each year for men and women of different ages, and a computer algorithm for calculating the implicit rates of return with different levels of monthly income over an uncertain horizon.

When these factors are taken into account, it turns out that the implied average rate of return on QLACs is even worse than the 2.5% average return on life insurance policies. Specifically, for the examples given in the Journal article, the implied average annual rates of return for individuals or couples of various ages range from 1.1% to 1.3%

The only way QLACs could ever be financial attractive is if you live many, many years past your life expectancy. For example, if Bob buys a QLAC with a death benefit and lives to 100, his implied annual return is 7.7%, which is getting closer but still not as good as stocks.

Of course, there is no guarantee that even the healthiest 65-year-old will live to 100. Accidents and unanticipated illnesses do happen. Just 0.7% of all 65-year-old men make it to 100. QLACs are certainly more attractive for people who expect to live a long time but for someone to assume, at age 65, that he or she will live to to 100 or beyond is delusional.

More realistically, suppose that Bob is so healthy that he has the annual death probabilities of someone five years younger. So at 65 he’s as healthy as someone who is 60; when he is 66, he has the death probability of someone 61, and so on. The implied average rates of return in that scenario are bumped a bit — to 2.3% with a death benefit and 2.7% without a death benefit, but QLACs are still a lot more financially attractive for companies selling them.

Many investing strategies are based on the presumption that people are risk averse, but QLACs go beyond risk aversion into risk-phobia. Buyers are sacrificing a lot to get very little. A more likely explanation for the appeal of QLACs is that buyers have no idea how bad the implied returns are.

Perhaps QLACs are just an expensive way of protecting people from making other bad decisions, like investing too cautiously (cash buried in the backyard?) or too impetuously (bitcoin anyone?), or living far beyond their means. For most people — who have other assets, Social Security income, and children who can help out if needed — loaning money to an insurance company at a 1%- to 2% interest rate is a lousy investment.

Gary Smith, Fletcher Jones Professor of Economics at Pomona College, is the author of dozens of research articles and 16 books, most recently, “Distrust: Big Data, Data-Torturing, and the Assault on Science” (Oxford University Press, 2023).

Read the full article here

News Room September 24, 2023 September 24, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Netflix stock falls after Q3 earnings miss, Tesla preview, OpenAI announces new web browser

Watch full video on YouTube

Why Americans are obsessed with denim

Watch full video on YouTube

Why bomb Sokoto? Trump’s strikes baffle Nigerians

It was around 10pm on Christmas Day when residents of the mainly…

Pressure grows on Target as activist investor builds stake

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Mosque bombing in Alawite district in Syria leaves at least 8 dead

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?